New hope for suicidal thoughts: nasal spray challenges shock therapy
NCT ID NCT06355180
Summary
This study tested whether a nasal spray medication called esketamine works as well as electroconvulsive therapy (ECT) for reducing suicidal thoughts in people with depression. Researchers compared the two treatments in 340 adults over 12 weeks to see which was better at quickly easing suicidal thoughts. The trial also looked at side effects and tried to understand how these treatments work in the brain.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUICIDAL IDEATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Anding Hospital
Beijing, Beijing Municipality, 100088, China
-
Beijing Chaoyang District Third Hospital
Beijing, China
-
Beijing Daxing District Xinkang Hospital
Beijing, China
-
Inner Mongolia Autonomous Region Mental Health Center
Hohhot, China
-
The Second People's Hospital of Dali Bai Autonomous Prefecture
Dali, China
-
Wuhu Fourth People's Hospital
Wuhu, Anhui, 241002, China
Conditions
Explore the condition pages connected to this study.